Loomis, Sayles & Company’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-334,381
Closed -$21.7M 920
2017
Q3
$21.7M Sell
334,381
-533
-0.2% -$32.6K 0.05% 257
2017
Q2
$18.1M Buy
334,914
+7,139
+2% +$380K 0.04% 284
2017
Q1
$18.3M Buy
327,775
+131,805
+67% +$6.92M 0.05% 276
2016
Q4
$9.64M Buy
+195,970
New +$10.8M 0.02% 440

Other funds holding PRTA

Loomis, Sayles & Company's PRTA Position: Q4 2017 in Review

Loomis, Sayles & Company sold out of Prothena Corp (PRTA) in Q4 2017, closing a stake of 334,381 shares — an estimated $21.7M sold.

Loomis, Sayles & Company first reported a position in PRTA in Q4 2016 and held it in 4 quarters. The position peaked at $21.7M in Q3 2017. 155 funds tracked by Wall St. Rank hold PRTA as of Q4 2017.

  • Loomis, Sayles & Company reported no remaining Prothena Corp position as of Q4 2017 after selling out during the quarter.
  • Loomis, Sayles & Company sold 334,381 Prothena Corp shares in Q4 2017, an estimated $21.7M.
  • Loomis, Sayles & Company first reported a position in Prothena Corp in Q4 2016 and held it in 4 quarters.
  • Loomis, Sayles & Company's Prothena Corp position peaked at $21.7M in Q3 2017.
  • 155 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2017.

Based on Loomis, Sayles & Company's 13F filing for Q4 2017, filed 14 Feb 2018.